There is a new treatment for prostate cancer thanks to Boston Scientific Institutes.
Dr. Jeffrey Mullins with CHI Memorial Urology Associates explains the process.
Cancer is a word no one takes lightly but when it comes to the treatment of prostate cancer Boston scientific has created a solution designed to increase the safety of prostate cancer treatment.
So prostate cancer is the most common malignancy in men and about 160 to 170,000 new cases per year in the US base 4 and OAR stands for Oregon at risk is basically this gel that we inject between the prostate and rectum and basically what it does.
In our Local Business Spotlight, Boston Scientific is bringing safer treatments to prostate cancer
Lyssa High talks with Dr. Thomas Curran, Chief Scientific Officer at Children's Mercy Research Institute and Jennifer and Aaron..